PALOMAR MEDICAL TECHNOLOGIES INC
DEFA14A, 1999-05-28
PRINTED CIRCUIT BOARDS
Previous: SELIGMAN HENDERSON GLOBAL FUND SERIES INC, 485BPOS, 1999-05-28
Next: ENHANCE FINANCIAL SERVICES GROUP INC, DEFA14A, 1999-05-28





                            SCHEDULE 14A INFORMATION

                PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

     FILED BY THE REGISTRANT /X/
     FILED BY A PARTY OTHER THAN THE REGISTRANT / /
     --------------------------------------------------------------------
     Check the appropriate box:

     / /  Preliminary Proxy Statement

     / /  Confidential, For Use of the
          Commission Only (as permitted by
          Rule 14a-6(e)(2))

     / /  Definitive Proxy Statement

     /X/  Definitive Additional Materials

     / /  Soliciting Material Pursuant to ss. 240.14a-11(c) or ss. 240.14a-12

                       PALOMAR MEDICAL TECHNOLOGIES, INC.
                ------------------------------------------------
                (Name Of Registrant As Specified In Its Charter)

                                 NOT APPLICABLE
                   ------------------------------------------
                   (Name Of Person(s) Filing Proxy Statement)

     PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):

     /X/  No fee required.

     /    / Fee computed on table below per Exchange Act Rules  14a-6(i)(4)  and
          0-11.

          1) Title of each class of securities to which transaction applies:
               N/A

          2)   Aggregate number of securities to which transaction applies: N/A

          3)   Per unit price or other underlying value of transaction  computed
               pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
               the filing fee is calculated and state how it was determined):
               $54,000,000

          4) Proposed maximum aggregate value of transaction:

          5) Total fee paid:

     / /  Fee paid previously with preliminary materials.

     /    / Check box if any part of the fee is offset as  provided  by Exchange
          Act Rule  0-11(a)(2)  and identify the filing for which the offsetting
          fee was paid previously.  Identify the previous filing by registration
          statement number, or the Form or Schedule and the date of its filing.

           1)  Amount Previously Paid:_____

           2)  Form, Schedule or Registration Statement No.:_____

           3)  Filing Party:_____

           4)  Date Filed: _____
<PAGE>
                       Palomar Medical Technologies, Inc.
                               45 Hartwell Avenue
                            Lexington, MA 02421-3102


                       CAUTION - PROXY CONTEST THREATENED


                                                                    May 28, 1999

DEAR FELLOW STOCKHOLDER:

         On Monday,  May 24, a dissident  group headed by Mark Smith and calling
itself "The Monterey  Stockholders Group LLC" announced it would attempt to take
over control of Palomar's  Board of Directors at the  Company's  annual  meeting
scheduled  for June 23, 1999.  The group is not offering to purchase your shares
or pay anything for control of the  Company.  Instead,  this group wants to gain
control of your Company -- and its over $50 million in cash from the recent sale
of its Star  subsidiary  -- by seeking  your vote to install  Mr.  Smith and his
three hand-picked candidates as Palomar's new board. YOUR BOARD OF DIRECTORS AND
MANAGEMENT  BELIEVE STRONGLY THAT ELECTING MR. SMITH'S  DISSIDENT  CANDIDATES IS
CONTRARY TO YOUR BEST  INTERESTS.  DO NOT SIGN ANY FORM OF PROXY YOU MAY RECEIVE
FROM THE MONTEREY GROUP.

         PLEASE SIGN, DATE AND MAIL ONLY THE ENCLOSED WHITE PROXY CARD SOLICITED
BY YOUR BOARD OF DIRECTORS.

                        WHO ARE THE DISSIDENT CANDIDATES?
                        WHAT ARE THEIR PLANS FOR PALOMAR?

         At this point,  the dissident group has yet to file its proxy materials
with the  Securities and Exchange  Commission,  and we do not know what specific
plans or proposals,  if any, they intend to implement.  However,  based on their
recent press release and our prior contacts with Mr. Smith,  we have learned the
following:

O        NONE OF THE  DISSIDENT  CANDIDATES  HAS ANY  EXPERIENCE IN THE COSMETIC
         LASER INDUSTRY.

O        NONE OF THE DISSIDENT CANDIDATES HAS EVER BEEN A DIRECTOR OR OFFICER OF
         A PUBLIC COMPANY.

O        THREE OF THE FOUR CANDIDATES -- UNLIKE YOU -- DO NOT OWN A SINGLE SHARE
         OF PALOMAR STOCK.  THEY ARE NOT EVEN ENTITLED TO VOTE FOR THEMSELVES AT
         THE ANNUAL MEETING.

O        THE  GROUP  SAYS IT  WANTS  TO USE THE  COMPANY'S  CAPITAL  AND  "OTHER
         RESOURCES," BUT IT DOESN'T SAY HOW OR WHO WOULD BENEFIT.

O        THE GROUP HAS VOICED VAGUE COMPLAINTS ABOUT YOUR COMPANY'S  OPERATIONS,
         YET IT  WANTS  TO  RETAIN  EXISTING  MANAGEMENT  WHILE  IT  CONDUCTS  A
         "STRATEGIC REVIEW."


<PAGE>



         We deeply regret that a costly and disruptive proxy contest is about to
be forced upon your Company at a time when the collective energies of your Board
and  management  should be devoted  fully  toward  restoring  value to Palomar's
stockholders.  IN THE TWO SHORT YEARS SINCE JOINING PALOMAR,  YOUR BOARD HAS LED
THE COMPANY FROM SIGNIFICANT LOSSES TO THREE CONSECUTIVE PROFITABLE QUARTERS. We
believe we have earned your  support,  and ask that we be  permitted to continue
our efforts on your behalf.

         We  will  prepare  and  distribute  additional  information  about  the
dissident group and its election  platform as soon as its proxy materials become
publicly available.  IN THE MEANTIME,  WE URGE YOU NOT TO RESPOND TO ANY REQUEST
FOR A PROXY YOU MAY RECEIVE FROM THE MONTEREY GROUP.

         PLEASE SIGN, DATE AND MAIL ONLY THE ENCLOSED WHITE MANAGEMENT PROXY.

         Your  interest  and  participation  in the affairs of your  Company are
sincerely appreciated.


                                   ON BEHALF OF THE BOARD OF DIRECTORS

                                   Sincerely,

                                   /s/ Louis P. Valente
                                   --------------------
                                   LOUIS P. VALENTE
                                   Chairman, Chief Executive Officer
                                   and President


If you have further  questions or need assistance,  please call Palomar at (781)
676-7300 or D. F. King & Co., Inc., which is assisting us with this matter, toll
free at (800) 628-8538


- -----------

The following may be deemed to be "participants" in this solicitation: Mr. Louis
P. Valente, who beneficially owns 435,000 shares of Palomar common stock, Mr. A.
Neil Pappalardo,  who beneficially  owns 250,000 shares of Palomar common stock,
Mr. James G.  Martin,  who  beneficially  owns 50,000  shares of Palomar  common
stock,  and Mr.  Nicholas P. Economou,  who  beneficially  owns 60,000 shares of
Palomar common stock.  These  participants  constitute your Board's nominees and
their stockholdings are as of April 9, 1999.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission